BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Actinium Announces Participation at the 2019 Cell & Gene Meeting on the Mesa

  Actinium to highlight its Iomab-ACT program for targeted lymphodepletion for CAR-T and other adoptive cell therapies

  September 30, 2019

   · 

  5 min read
• Pharm Country

  IVERIC bio to Present at the Chardan Capital Markets 3rd Annual Genetic Medicines Conference

  IVERIC bio, Inc. announced that Glenn P. Sblendorio, Chief Executive Officer and President of IVERIC bio, will present an overview of the Company at the Chardan Capital Markets 3rd Annual Genetic Medicines Conference in New York on Monday, October 7, 2019 at 8:30 a.m. Eastern Time.

  September 30, 2019

   · 

  1 min read
• BioCapital

  Emmes Ranked as a Top Private Company

  Company Offices in Rockville, Frederick and Tysons Corner Allow Employees to Choose a Location Closest to Home

  September 30, 2019

   · 

  1 min read
• Jazz Pharmaceuticals Survey Highlights Prevalence of Misinformation and Misperception About Narcolepsy Among Americans

  Jazz Pharmaceuticals announces findings from a consumer survey underscoring a need for better understanding of sleep disorders

  September 30, 2019

   · 

  8 min read